IDEXX Laboratories Inc. (IDXX)

200.76
NASDAQ : Health Technology
Prev Close 195.59
Day Low/High 195.15 / 201.25
52 Wk Low/High 146.09 / 217.89
Avg Volume 473.90K
Exchange NASDAQ
Shares Outstanding 86.86M
Market Cap 18.19B
EPS 3.00
P/E Ratio 61.51
Div & Yield N.A. (N.A)
Idexx Laboratories (IDXX) Hits New Lifetime High

Idexx Laboratories (IDXX) Hits New Lifetime High

Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a new lifetime high candidate

Insider Trading Alert - IDXX, AGN And BGC Traded By Insiders

Insider Trading Alert - IDXX, AGN And BGC Traded By Insiders

Stocks with insider trader activity include IDXX, AGN and BGC

Idexx Laboratories (IDXX) Reaches New Lifetime High Today

Idexx Laboratories (IDXX) Reaches New Lifetime High Today

Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a new lifetime high candidate

Idexx Laboratories (IDXX) Reaches New Lifetime High Today

Idexx Laboratories (IDXX) Reaches New Lifetime High Today

Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a new lifetime high candidate

New Lifetime High For Idexx Laboratories (IDXX)

New Lifetime High For Idexx Laboratories (IDXX)

Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a new lifetime high candidate

Insider Bets Paying Off At IDXX As New 52-Week High Reached

Insider Bets Paying Off At IDXX As New 52-Week High Reached

In trading on Friday, shares of Idexx Laboratories, Inc. touched a new 52-week high of $113.40/share.

Idexx Laboratories Larger Than S&P 500 Component QEP Resources

Idexx Laboratories Larger Than S&P 500 Component QEP Resources

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Idexx Laboratories, Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example QEP Resources Inc , according to The Online Investor.

Short Interest In Idexx Laboratories Moves 14.2% Lower

Short Interest In Idexx Laboratories Moves 14.2% Lower

The most recent short interest data has been released by the NASDAQ for the 12/13/2013 settlement date, which shows a 630,448 share decrease in total short interest for Idexx Laboratories, Inc. , to 3,813,650, a decrease of 14.19% since 11/29/2013.

4 Stocks Rising on Unusual Volume

4 Stocks Rising on Unusual Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

4 Health Care Stocks to Watch

4 Health Care Stocks to Watch

Keep an eye on these health care stocks trading on unusual volume.

IDXX: Insiders Vs. Shorts

IDXX: Insiders Vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 10/31/2013 settlement date, and Idexx Laboratories, Inc. is one of the most shorted stocks of the Russell 3000, based on 14.28 "days to cover" versus the median component at 4.31.

Insider Trading Alert - REGN, HK, IFF, IDXX And WLL Traded By Insiders

Insider Trading Alert - REGN, HK, IFF, IDXX And WLL Traded By Insiders

Stocks with insider trader activity include REGN, HK, IFF, IDXX and WLL

Insider Trading Alert - SFY, GWRE, ZNGA, IDXX And AXE Traded By Insiders

Insider Trading Alert - SFY, GWRE, ZNGA, IDXX And AXE Traded By Insiders

Stocks with insider trader activity include SFY, GWRE, ZNGA, IDXX and AXE

New Lifetime High Reached: Idexx Laboratories (IDXX)

New Lifetime High Reached: Idexx Laboratories (IDXX)

Trade-Ideas LLC identified Idexx Laboratories (IDXX) as a new lifetime high candidate

Today's Stocks Driving Success For The Drugs Industry

Today's Stocks Driving Success For The Drugs Industry

TheStreet highlights 5 stocks pushing the drugs industry higher today.

Idexx Rises On Unusually High Volume (IDXX)

Idexx Rises On Unusually High Volume (IDXX)

Idexx Laboratories (Nasdaq:IDXX) is trading at unusually high volume Thursday with 789,860 shares changing hands. It is currently at two times its average daily volume and trading up $3.19 (+3.8%).

Idexx Laboratories (IDXX): Today's Featured Health Care Laggard

Idexx Laboratories (IDXX): Today's Featured Health Care Laggard

Idexx Laboratories was a leading decliner within the health care sector, falling $3.35 (-3.7%) to $86.65 on heavy volume

4 Stocks Rising on Big Volume

4 Stocks Rising on Big Volume

Often when above-average volume moves into an equity, it precedes a large spike in volatility.

Under-the-Radar Hot Industries For Small Business Profits

Under-the-Radar Hot Industries For Small Business Profits

Veterinarian health care, ambulance services and lab testing are industries ripe with profit potential for entrepreneurs seeking a new business venture.

Buy the 5 Pharma Stocks Everyone Hates

Buy the 5 Pharma Stocks Everyone Hates

Any of these short-squeeze plays could be the cure for a sluggish portfolio.

IDEXX Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q2 2012 Results - Earnings Call Transcript

Idexx Stock Hits New 52-Week High (IDXX)

Idexx Stock Hits New 52-Week High (IDXX)

Idexx Laboratories (Nasdaq:IDXX) hit a new 52-week high Monday as it is currently trading at $89.69, above its previous 52-week high of $89.62 with 38,692 shares traded as of 12:28 p.m. ET. Average volume has been 253,300 shares over the past 30 days.

Bull Power Is Limited

As more cash is thrown at the market without a decent payoff, there will be less supply available for a bounce.

IDEXX Laboratories' CEO Hosts Annual Shareholder Meeting Conference (Transcript)

IDEXX Laboratories' CEO Hosts Annual Shareholder Meeting Conference (Transcript)

IDEXX Laboratories' CEO Hosts Annual Shareholder Meeting Conference (Transcript)

Idexx Reaches New 52-Week High (IDXX)

Idexx Reaches New 52-Week High (IDXX)

Idexx Laboratories (Nasdaq:IDXX) hit a new 52-week high Tuesday as it is currently trading at $89.50, above its previous 52-week high of $89.50 with 108,287 shares traded as of 12:34 p.m. ET. Average volume has been 253,900 shares over the past 30 days.

IDEXX Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Idexx Reaches New 52-Week High (IDXX)

Idexx Reaches New 52-Week High (IDXX)

Idexx Laboratories (Nasdaq:IDXX) hit a new 52-week high Wednesday as it is currently trading at $87.80, above its previous 52-week high of $87.69 with 72,865 shares traded as of 11:55 a.m. ET. Average volume has been 251,200 shares over the past 30 days.

IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript

IDEXX Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Spending On Pets Still Strong, Says Heska CEO

Spending On Pets Still Strong, Says Heska CEO

Dr. Robert Grieve, CEO of Heska Corp., says Americans continue to spend on their pets welfare despite the slow economy.

IDEXX Laboratories CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript)

IDEXX Laboratories CEO Presents At 30th Annual JP Morgan Healthcare Conference (Transcript)

IDEXX Laboratories CEO Presents at 30th Annual JP Morgan Healthcare Conference (Transcript)

TheStreet Quant Rating: B- (Buy)